More than 4,000 nurses at Brigham and Women’s Hospital and roughly 450 home health workers walked off the job Wednesday, launching what union officials call the largest healthcare labor strike
Why the Future of IDR Depends on Smarter Technology
As the No Surprises Act’s independent dispute resolution (IDR) process has matured, discourse has abounded, with much of the narrative focused on whether providers are overusing the system to maximize
Healthcare and AI are in Need of Relationship Counseling
Patients across the world are increasingly seeking medical guidance from artificial intelligence systems. In a recent Times of India report, after multiple specialists failed to identify the cause of a
Ascension to Buy Tennessee Health System for Nearly $1B
This month, the board of trustees for Williamson Health, a county-owned health system in Tennessee, voted unanimously to sell the organization to Ascension Saint Thomas, Ascension‘s Tennessee division. Ascension plans
The AI Use Case That Healthcare is Overlooking
“We spend more time chasing inventory than taking care of our patients.” Every week, I talk to pharmacy directors and supply chain leaders at health systems across the country, and
Why Penn Medicine Is Deploying AI Agents for Patient Intake
Many of the healthcare AI tools hitting the market in the past few years have been built to lighten the load on clinicians — with less attention being paid to
Report Highlights Private Equity’s Lesser-Known Strategy: Nonprofit Joint Ventures
It’s well known that private equity has drastically increased its presence in the healthcare industry, acquiring hospitals, physician practices and other providers. These acquisitions have received scrutiny following the bankruptcies
In Oncology, the Cost Problem Goes Beyond Predictability
Oncology remains one of the most challenging areas for payers since it is literally in the eye of a perfect storm of expensive medications, high-cost specialized therapies, changing reimbursement rules
Lung-Focused Celea Secures $180M for Pivotal Test of Pulmonary Fibrosis Drug
One of the standard treatments for idiopathic pulmonary fibrosis is an old drug that offers limited efficacy and a range of side effects. Celea Therapeutics aims to offer advantages over
Orca Bio Cell Therapy Gets Landmark FDA Nod for New Kind of Living Medicine
Many blood cancers can be treated with a potentially curative stem cell transplant, but this procedure introduces a serious complication risk that can become deadly. A new type of cell









